Mereo BioPharma Group (MREO)
undefined
undefined%
At close: undefined
3.76
1.21%
After-hours Dec 13, 2024, 04:00 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Cash & Equivalents 57.42M 56.33M 94.30M 23.47M 16.35M 25.04M 50.04M 53.58M 79.68M
Short-Term Investments - 51.10M 569.00K 547.00K 544.00K 2.50M 2.50M - -
Long-Term Investments - - - - - - - - -
Other Long-Term Assets - -25.95M -27.09M -33.22M -56.01M - - - -
Receivables 3.73M 2.75M 1.42M 1.02M - - - - -
Inventory - -2.67M -1.82M -4.64M -11.98M -293.33K -2.50M -53.92M -
Other Current Assets 2.61M 4.27M 5.03M 1.62M 2.11M 6.95M 10.63M 7.20M 1.60M
Total Current Assets 63.76M 62.13M 99.32M 29.73M 30.43M 34.50M 63.18M 60.78M 81.28M
Property-Plant & Equipment 1.65M 1.83M 2.53M 1.57M 11.56M 148.94K 153.36K 173.87K 204.52K
Goodwill & Intangibles 1.09M 24.12M 24.56M 31.65M 44.46M 32.63M 33.01M 25.81M 25.81M
Total Long-Term Assets 2.74M 25.95M 27.09M 33.22M 56.01M 32.78M 33.16M 25.99M 26.02M
Total Assets 66.50M 88.08M 126.42M 62.95M 86.45M 67.28M 96.34M 86.76M 107.30M
Account Payables 2.35M 3.49M 2.29M 2.94M 5.88M 5.57M 2.64M 1.23M 1.08M
Deferred Revenue - - 8.37M - 5.45M -177.71K -163.72K - -
Short-Term Debt 652.00K 11.59M 622.00K 636.00K 17.73M 6.84M 1.94M - -
Other Current Liabilities 5.83M 9.43M 7.92M 7.95M 6.09M 3.60M 8.27M 1.87M 4.81M
Total Current Liabilities 9.49M 24.68M 12.54M 8.56M 29.88M 16.18M 9.62M 3.21M 2.82M
Long-Term Debt 5.30M 1.48M 1.75M 17.30M 19.26M 14.65M 18.81M 3.13M 2.80M
Other Long-Term Liabilities 1.18M 54.00K 36.04M 59.98M 24.34M 3.68M 5.42M 1.17M 141.31K
Total Long-Term Liabilities 6.48M 1.53M 25.87M 69.35M 16.32M 18.33M 24.23M 4.30M 2.94M
Total Liabilities 15.96M 26.21M 38.41M 77.92M 46.19M 34.51M 33.85M 7.51M 5.76M
Total Debt 5.95M 12.77M 16.76M 17.94M 32.42M 21.48M 20.75M 3.13M 2.80M
Common Stock 2.77M 1.88M 1.75M 1.02M 294.00K 213.72K 213.28K 193.02K 59.22K
Retained Earnings -419.63M -331.16M -296.97M -309.69M -146.06M -111.22M -79.32M -33.58M -12.19M
Comprehensive Income -17.48M 137.91M 136.90M 133.22M 47.32M 25.59M 23.36M 12.67M -
Shareholders Equity 50.54M 61.87M 88.00M -14.97M 40.26M 32.77M 62.48M 79.26M 101.54M
Total Investments - 51.10M 569.00K 547.00K 544.00K 2.50M 2.50M - -